IL6 and amyotrophic lateral sclerosis: Although the role of IL-6 in neuromuscular pathologies is not fully understood, elevated IL-6 levels have been used as a disease progression biomarker in certain groups of amyotrophic lateral sclerosis (ALS) patients, specifically those with the IL6R358Ala variant [57].